Stroke
May 2013 hospitals in China are classified into 3 grades: I (community hospitals); II (hospitals that serve several communities); and III (central hospitals for a certain district or city). In total, 242 potential sites, including 114 grade III, 71 grade II, and 57 grade I hospitals, from both urban and rural area, were initially identified by soliciting application. The CNSR steering committee evaluated the research capability and commitment to the registry of each hospital with preliminary survey. Finally, a total of 132 hospitals including 100 grade III and 32 grade II were selected, which cover 27 provinces and 4 municipalities across China. Trained research coordinators at each institute reviewed medical records daily to identify, consent, and enroll consecutively eligible patients. To be eligible for this study, subjects had to meet the following criteria:
(1) age ≥18 years; (2) hospitalized with a primary diagnosis of AIS according to World Health Organization criteria 30 ; (3) stroke confirmed by head computerized tomography or brain MRI; (4) direct admission to hospital from a physician's clinic or emergency department. The eligible patients from the CNSR were randomly classified into derivation cohort (60%) and internal validation cohort (40%).
External Validation Cohort
The external validation cohort was derived from the cohort of Chinese Intracranial Atherosclerosis Study (CICAS). CICAS was a multicenter and prospective study aiming at investigating prevalence, risk factors, and impact of intracranial atherosclerosis among patients with ischemic stroke. 31 The CICAS inclusion criteria were as follows: (1) age between 18 and 80 years; (2) onset of symptom within 7 days; and (3) hospitalized with a primary diagnosis of AIS or transient ischemic attack. Exclusion criteria were as follows: (1) preadmission modified Rankin Scale score >3; and (2) inability to undergo MRI for cerebral vascular imaging. For this study, patients diagnosed of transient ischemic attack were excluded.
Data Collection and Definitions
The scientific use of data obtained with informed consent and entered in the CNSR and CICAS registries was approved by the local ethical committees. In these registries, a standardized case report form was used for data collection in the CNSR and CICAS network. The relevant data were extracted from the medical records by trained research coordinators. Data from each case report form were manually checked for completeness, correct coding, and proper application of diagnostic algorithm by a research specialist from an independent contract research organization. For the present study, the following candidate variables were analyzed: (1) demographics (age and sex); (2) stroke risk factors: hypertension (history of hypertension or antihypertensive medication use), diabetes mellitus (history of diabetes mellitus or antidiabetic medication use), dyslipidemia (history of dyslipidemia or lipid-lowering medication use), atrial fibrillation (history of atrial fibrillation or documentation of atrial fibrillation at admission), coronary heart disease, history of stroke/transient ischemic attack, current smoking, and excess alcohol consumption (≥2 standard alcohol beverages per day); (3) pre-existing comorbidities: congestive heart failure, valvular heart disease, peripheral artery disease, chronic obstructive pulmonary disease, hepatic cirrhosis, peptic ulcer, previous gastrointestinal bleeding, renal failure, arthritis, Alzheimer's disease/dementia, and cancer; (4) prestroke dependence (modified Rankin Scale ≥3); (5) admission stroke severity based on National Institutes of Health Stroke Scale score (NIHSS) and Glasgow Coma Scale score; (7) symptom of dysphagia; (8) stroke subtype: according to the Oxfordshire Community Stroke Project criteria, 32 AIS was classified into partial anterior circulation infarct, total anterior circulation infarct, lacunar infarction, and posterior circulation infarct; (9) admission blood glucose (mmol/L); and (10) length of hospital stay (days).
In this study, SAP was diagnosed by treating physician according to the Centers for Disease Control and Prevention criteria for hospital-acquired pneumonia, 33 on a basis of clinical and laboratory indices of respiratory tract infection (fever, cough, auscultatory respiratory crackles, new purulent sputum, or positive sputum culture), and supported by typical chest X-ray findings. Only hospital-acquired pneumonia was documented and pneumonia before stroke was not considered. Data on in-hospital SAP was prospectively collected.
Statistical Analysis
Model building was performed exclusively in the derivation cohort. In univariate analysis, χ 2 test was used to compare categorical variables, and Mann-Whitney test was used to compare continuous variables. Univariate and multivariable logistic regression was performed to determine the independent predictors of SAP after AIS in the derivation cohort. Candidate variables were those with biologically plausible link to SAP on the basis of prior publication and those associated with SAP in univariate analysis (P<0.2). On multivariable analysis, stepwise backward estimation was used to remove nonsignificant variables from the model. To test for collinearity between the covariates of the final multivariable model, the tolerance and variance inflation factor of each covariate was calculated. The β-coefficients from the final model were used to generate point scoring system of the AIS-APS, as in previous studies. 34 The resulting AIS-APS was then validated by assessing model discrimination and calibration, 35 in the internal and external validation cohorts. Discrimination was assessed by calculating the area under the receiver operating characteristic curve (AUROC). Calibration was assessed by performing the Hosmer-Lemeshow goodness-of-fit test and was graphically depicted in the plot of observed versus predicted SAP risk according to 10 deciles of predicted risk. Furthermore, we compared the discrimination of the AIS-APS and 3 prior scores, [25] [26] [27] with regard to in-hospital SAP after AIS. The AUROC and maximum Youden index were used to assess the discrimination of these scores for in-hospital SAP after AIS. AUROC was compared using Delong method, 36 and sensitivity, specificity, positive predict value, and negative predictive value were calculated at each score's maximum Youden index.
All tests were 2-tailed, and statistical significance was determined at α level of 0.05. Statistical analysis was performed using SAS 9.1 (SAS Institute, Cary, NC), SPSS 17.0 (SPSS Inc, Chicago, IL), and Medcalc software 12.3 (MedCalc, Ostend, Belgium) .
Results

Clinical Characteristics
The clinical characteristics of the derivation, internal and external validation cohort were shown in Table 1 [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] , and a total of 1669 (11.4%) patients had SAP during hospitalization. The eligible patients from the CNSR were randomly classified into derivation cohort (60%, n=8820) and internal validation cohort (40%, n=5882), which were well matched with respect to patient characteristics and overall rate of in-hospital SAP (Table 1) .
From October 2007 to June 2009, a total of 3580 patients of AIS were registered in 22 participating hospitals in the CICAS network. Of these, we excluded 329 patients with transient ischemic attack (9.1%; median age, IQR: 62, 54-71; median admission NIHSS, IQR: 0, 0-1) and an additional 214 (6.0%; median age, IQR: 64, 55-73; median admission NIHSS, IQR: 3, 0-6) who had missing data of ≥1 covariates in the AIS-APS. The median length of hospital stay was 14 days (IQR, [10] [11] [12] [13] [14] [15] [16] [17] [18] , and a total of 222 (7.3%) patients had SAP during hospitalization ( Table 1) .
Predictors of In-hospital SAP
The univariate analysis for potential predictors of in-hospital SAP after AIS in the derivation cohort was shown in Table  I in the online-only Data Supplement, and the multivariable predictors were listed in Table 2 . Age, present history of atrial fibrillation, congestive heart failure, chronic obstructive pulmonary disease, and current smoking, prestroke dependence (modified Rankin Scale>3), admission NIHSS score, Glasgow Coma Scale score, symptom of dysphagia, Oxfordshire Community Stroke Project subtype of total anterior circulation infarct and posterior circulation infarct, and blood glucose were significantly predictive of in-hospital SAP after AIS. The tolerance of covariates in the final multivariable model ranged between 0.66 and 0.99; the mean variance inflation factor was 1.16 (range, 1.02-1.68).
Derivation of the AIS-APS
The β-coefficients from the multivariable regression model were used to generate point scoring system of the AIS-APS. To derive an integer value for each predictor, the β-coefficient of current smoking was used as reference and the value was rounded to the closest integer. The point scoring system of the AIS-APS was shown in Figure 1 . The median AIS-APS score was 8 (range, 0-32) in the derivation cohort. The risk categories were assigned in 7-point increments, and the magnitude of the score had prognostic implication ( Figure 2 ). 
Internal Validation of the AIS-APS
The performance of the AIS-APS (AUROC) in the derivation (n=8820) and internal validation cohort (n=5882) 
External Validation of the AIS-APS
In the external validation cohort (n=3037), the AIS-APS showed good discrimination with an AUROC of 0.792 (95% confidence interval, 0.761-0.823). The Hosmer-Lemeshow test was not significant (P=0.30). The plot of observed versus predicted risk of in-hospital SAP after AIS showed high correlation between observed and predicted risk in the external validation cohort ( Figure I in the online-only Data Supplement).
Sensitivity Analysis
We completed prespecified subgroup analyses by age, sex, time delay from onset to hospital arrival, and length of hospital stay. Similar good discrimination was seen in these subgroups (AUROC range, 0.740-0.837) ( Table III in the online-only Data Supplement). Table 3 showed the discrimination of the AIS-APS and 3 compared prior scores for in-hospital SAP after AIS. Although Chumbler and Hoffmann scores consistently showed good discrimination for in-hospital SAP in the derivation, internal and external validation cohort, the AIS-APS demonstrated the highest AUROC. The difference in AUROC between AIS-APS and 3 compared scores was statistically significant (all P<0.0001). The AIS-APS had the highest maximum Youden index and associated sensitivity, specificity, positive predict value and negative predictive value (Table 3) .
Comparison of SAP Scores
Discussion
In the present study, we derived and validated a risk score for predicting in-hospital SAP after AIS. A 34-point AIS-APS was developed from the set of independent predictors. The AIS-APS showed good discrimination and calibration in the derivation, internal and external validation cohort. When compared with 3 prior scores, the AIS-APS showed significantly better discrimination with regard to in-hospital SAP after AIS.
To preserve the clinical use of the model for decision-making during acute hospitalization, we used only patient characteristics available at presentation. We chose not to include variables related to in-hospital management and those not routinely collected, such as quality of care, 37 mechanical ventilation, and swallowing test, 11, 38 despite the fact that these factors might influence the development of SAP after AIS. This model therefore predicts the expected risk of in-hospital SAP at presentation, and as such, the predictions could be used to guide subsequent in-hospital management.
Several risk factors for SAP have been identified. Consistent with these studies, we confirmed that in-hospital SAP was significantly associated with older age, present history of atrial fibrillation, congestive heart failure, chronic obstructive pulmonary disease and smoking, prestroke dependence, admission NIHSS score, Glasgow Coma Scale score, dysphagia, and stroke subtypes. In addition, our study showed that admission blood glucose was significantly associated with in-hospital AIS indicates acute ischemic stroke; CI, confidence interval; COPD, chronic obstructive pulmonary disease; GCS, Glasgow Coma Scale; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; OCSP, Oxfordshire Community Stroke Project; OR, odds ratio; and SAP, stroke-associated pneumonia.
*Multivariable logistic regression adjusted for age, sex, stroke risk factors, comorbidities, prestroke dependence, admission NIHSS score, GCS score, symptom of dysphagia, OCSP subtypes, blood glucose, and length of hospital stay.
by guest on April 30, 2017 http://stroke.ahajournals.org/ Downloaded from SAP after AIS. Prior studies have indicated the relationship between blood glucose and in-hospital acquired infections. 39, 40 Biological evidence demonstrates that diabetes mellitus can increase susceptibility of infection by compromising the immune system. For example, neutrophils from people with diabetes mellitus showed reduced chemotaxis and oxidative killing potential compared with those from nondiabetes controls. 41 Leukocyte bactericidal activity is diminished in those with poor glucose control. 42 The present risk stratification and prognostic model for SAP is unique in that it was derived from a large, multicenter, and prospective cohort, which included consecutive patients of AIS, was outside of clinical trial, and was more reflective of real-world clinical practice; the model included comprehensive information on demographics, medical history, prestroke functional status, admission stroke-related characteristics, and laboratory test; in addition, it could be used to predict in-hospital SAP on hospital arrival and could be readily incorporated into clinical practice by performing a simple score. Several SAP prediction rules have been developed using similar techniques; however, these models have not been widely used in clinical practice. It is not our intention to show superiority of the AIS-APS compared to the earlier scores; however, we want to point out the major difference. Kwon et al 27 developed a pneumonia score, which included age, sex, NIHSS score, mechanical ventilation, and dysphagia. However, the study was limited by small sample size and was not validated externally. Sellars et al 11 presented key predictors for poststroke pneumonia, including older age, dysarthria or no speech due to aphasia, modified Rankin Scale score >4, low abbreviated mental test score, and failed water swallowing test. Although the model was informative, some predictors were not routinely collected. Chumbler et al 25 presented a 3-level scoring system for predicting pneumonia in acute stroke, which included medical history of pneumonia, symptom of dysphagia, increasing NIHSS score, being found down at symptom onset, and age >70 years. Although the model showed acceptable C-statistics, the study was limited by its retrospective nature and lacking of validation. Hoffmann et al 26 derived Figure 1 . Acute ischemic stroke-associated pneumonia score (AIS-APS). COPD indicates chronic obstructive pulmonary disease; GCS, Glasgow Coma Scale; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; and OCSP, Oxfordshire Community Stroke Project. a score (A2DS2) to predict pneumonia after AIS in a large derivation and validation sample. The model showed good discrimination and calibration properties; however, it was not externally validated in geographically, culturally, and socioeconomically distinct population. With several SAP-related risk stratification and prognostic models available, identification of the most accurate and reliable grading scale(s) would be of great value to patients, clinicians, and researchers. In this study, we compared the discrimination of the AIS-APS and 3 prior scores with regard to in-hospital SAP after AIS. When using 2 measures to assess model discrimination (AUROC and maximum Youden index), the AIS-APS consistently showed to be superior at predicting in-hospital SAP after AIS than 3 compared scores in our population. In addition, similar results were verified in the derivation, internal and external validation cohort. It was noteworthy that all scales had higher negative predictive value than positive predict value for in-hospital SAP after AIS, which suggested that lower values more consistently predict patients without in-hospital SAP than higher values predicting those developing in-hospital SAP after AIS. Development of future prognostic models might benefit from attempts to make them more balanced in this regard, with discriminative use distributed more evenly among higher and lower values.
Prior studies have shown that SAP was an important risk factor of mortality and morbidity after stroke; however, a systematic review on efficacy of early antibiotics prophylaxis after stroke failed to show benefit in patients' outcome. 43 This might be attributable to inclusion of patients with low risk of developing SAP in these studies. The AIS-APS and other SAP predictive tools could be used to identify patients who are at high risk of developing SAP after stroke. It is expected that randomized controlled trials on efficacy of antibiotics prophylaxis on stroke functional outcome with stratification of patients' potential risk of developing SAP.
Our study had some limitations that deserve comment. First, as all observational studies, we cannot rule out the possibility that additional baseline variable (unmeasured confounders) might have some impact on the development of in-hospital SAP after AIS, such as use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers. 44 Second, the time course of SAP after AIS is unclear. Because we only have information on new-onset SAP during hospitalization without documentation of the exact date, our data allow no conclusion as to whether patients with a longer length of stay per se are more likely to develop pneumonia or whether diagnosis of pneumonia leads to a longer hospitalization. However, by sensitive analysis, the AIS-APS was proven to be valid and significant, regardless of length of hospital stay. Third, the limited information on time course of pneumonia also does not allow for a safe interpretation of causality between mechanical ventilation and pneumonia. We therefore abstained from including mechanical ventilation in our predictive score. In addition, the primary aim of our study was to develop a predictive score for SAP after AIS at presentation. Fourth, the study included only hospitalized patients with stroke, and those patients died in the emergency department, shortly after admission, or treated in outpatient clinics were not included. Meanwhile, the results of current analysis apply only to patients of AIS and cannot be extrapolated to patients of hemorrhagic stroke. Finally, the AIS-APS need to be further validated in additional populations.
In summary, the AIS-APS is a valid clinical grading scale for predicting in-hospital SAP after AIS at presentation. Further studies on effect of AIS-APS on stroke outcomes are needed.
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The Plot of observed versus predicted risk of in-hospital SAP after AIS with 95% confidence interval (C.I.) in the derivation and validation cohorts according to 10 deciles of predicted risk. Overall, there was a very high correlation between observed and predicted risk in the derivation cohort (A) (n=8820; r=0.99, P<0.001), internal validation cohort (B) (n=5882; r=0.99, P<0.001), and external validation cohort (C) (n=3037; r=0.98, P<0.001), which indicated excellent calibration.
